KRYS
Krystal Biotech Inc
Price:  
125.96 
USD
Volume:  
380,465.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KRYS Probability of Bankruptcy

The Probability of Bankruptcy of Krystal Biotech Inc (KRYS) is 1.41% . This number represents the probability that KRYS will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating KRYS's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

KRYS - ESG ratings

ESG ratings are directly linked to the cost of capital and KRYS's ability to raise funding, both of which can significantly affect the probability of Krystal Biotech Inc going bankrupt.

ESG Score 64.71
Environment Score 53.05
Social Score 74.44
Governance Score 66.63
Returns
Historical Returns (5 day) 0.73%
Historical Returns (MTD) -25.85%
Historical Returns (YTD) -19.60%
Historical Returns (13 week) -27.34%
Historical Returns (26 week) -29.28%
Historical Returns (52 week) -19.44%
Efficiency
Asset Turnover 0.33
Receiveable Turnover 4.45
Gross Margin 93.20%
Operating Margin 32.56%
Pretax Margin 41.39%
Net Margin 37.18%
Return on Asset (ROA) 12.30
Return on Equity (ROE) 13.56
Return on Investments (ROI) 13.56
Price Metrics
Market Cap (M) 3,640.24
Enterprise Value (M)
52 Week High 219.34
52 Week Low 122.80
Beta 0.67
Average Volume (10 day) 0.36
Average Volume (3 month) 0.31
Price / Earnings (P/E) 29.59
Price / Sales (P/S) 11.00
Earnings
EPS 4.15
Revenue CAGR (5 year)
Risk
Current Ratio 9.65
Quick Ratio 9.06